Skip to main content
    • Aa
    • Aa

Evaluation of Hospital Room Assignment and Acquisition of Clostridium difficile Infection

  • Megan K. Shaughnessy (a1), Renee L. Micielli (a1), Daryl D. DePestel (a2), Jennifer Arndt (a3), Cathy L. Strachan (a4), Kathy B. Welch (a5) and Carol E. Chenoweth (a1) (a3)...
Background and Objective.

Clostridium difficile spores persist in hospital environments for an extended period. We evaluated whether admission to a room previously occupied by a patient with C. difficile infection (CDI) increased the risk of acquiring CDI.


Retrospective cohort study.


Medical intensive care unit (ICU) at a tertiary care hospital.


Patients admitted from January 1, 2005, through June 30, 2006, were evaluated for a diagnosis of CDI 48 hours after ICU admission and within 30 days after ICU discharge. Medical, ICU, and pharmacy records were reviewed for other CDI risk factors. Admitted patients who did develop CDI were compared with admitted patients who did not.


Among 1,844 patients admitted to the ICU, 134 CDI cases were identified. After exclusions, 1,770 admitted patients remained for analysis. Of the patients who acquired CDI after admission to the ICU, 4.6% had a prior occupant without CDI, whereas 11.0% had a prior occupant with CDI (P = .002). The effect of room on CDI acquisition remained a significant risk factor (P = .008) when Kaplan-Meier curves were used. The prior occupant's CDI status remained significant (P = .01; hazard ratio, 2.35) when controlling for the current patient's age, Acute Physiology and Chronic Health Evaluation III score, exposure to proton pump inhibitors, and antibiotic use.


A prior room occupant with CDI is a significant risk factor for CDI acquisition, independent of established CDI risk factors. These findings have implications for room placement and hospital design.

Corresponding author
3119 Taubman Center, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5378 (
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. JG Bartlett , DN Gerding . Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008;46(suppl 1): S12S18.

2. DN Gerding , CA Muto , RC Owens . Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008;46(suppl 1):S43S49.

3. L Kyne , MB Hamel , R Polavaram , CR Kelly Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346353.

4. KH Kim , R Fekety , DH Batts , et al.Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981;143:4250.

5. SS Huang , R Datta , R Platt . Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006;166:19451951.

6. VT Chang , K Nelson . The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 2000;31:717722.

7. ER Dubberke , KA Reske , MA Olsen , et al.Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C. difficile-associated disease. Arch Intern Med 2007;167:10921097.

9. SV Kazakova , K Ware , B Baughman , et al.A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006;166:25182524.

11. VG Loo , L Poirier , MA Miller , et al.A predominately clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:24422449.

12. J Pepin , N Saheb , M Coulombe , et al.Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:12541260.

13. ER Dubberke , KA Reske , Y Yan , MA Olsen , LC McDonald , VJ Fraser . Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007;45:15431549.

14. RC Owens , CJ Donskey , RP Gaynes , VG Loo , CA Muto . Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008;46(suppl 1):S19S31.

15. ME McCusker , AD Harris , E Perencevich , M Roghmann . Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis 2003;9:730733.

17. R Cunningham , B Dale , B Undy , N Gaunt . Proton pump inhibitors as a risk factor for Clostridium difficile diarrhea. J Hosp Infect 2003;54:243245.

18. DZ Bliss , S Johnson , K Savik , CR Clabots , K Willard , DN Gerding . Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 1998;129:10121019.

20. RE Polk , C Fox , A Mahoney , J Letcavage , C MacDougall . Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664670.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 0
Total number of PDF views: 39 *
Loading metrics...

Abstract views

Total abstract views: 643 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th September 2017. This data will be updated every 24 hours.